By Kali Hays ( November 4, 2016, 3:43 PM EDT) -- The Sloan-Kettering Institute for Cancer Research on Thursday called for sanctions against an independent biopharmaceutical company trying to get back certain rights to a type of gene therapy for a blood disease and its counsel, arguing there have been multiple "willful" violations of a strict protective order....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.